ANTIBODY RESPONSE TO HIGH-DOSE TRIVALENT VS STANDARD-DOSE QUADRIVALENT INFLUENZA VACCINE IN PATIENTS WITH HIGH-RISK CARDIOVASCULAR DISEASE: THE INVESTED TRIAL

被引：0

作者：

Peikert, Alexander ^{[1
]}

Claggett, Brian ^{[1
]}

Udell, Jacob A. ^{[1
]}

Joseph, Jacob ^{[1
]}

Hegde, Sheila M. ^{[1
]}

Mao, Lu ^{[1
]}

Wang, Tuo ^{[1
]}

Havighurst, Thomas ^{[1
]}

Farkouh, Micheal ^{[1
]}

Bhatt, Deepak L. ^{[1
]}

Tattersall, Matthew C. ^{[1
]}

Cooper, Lawton S. ^{[1
]}

Solomon, Scott D. ^{[1
]}

Vardeny, Orly ^{[1
]}

机构：

[1] Brigham & Womens Hosp, Harvard Med Sch, Boston, MA USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1473-223

引用

页码：2003 / 2003

页数：1

共 50 条

[41] AEs with high- and standard-dose influenza vaccine in ESRD
Reactions Weekly, 2020, 1811 (1) : 6 - 6
[42] Relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine according to time of day of vaccination: a post-hoc analysis of the DANFLU-1 randomised clinical trial
Christensen, J.
Johansen, N. D.
Janstrup, K. H.
Modin, D.
Nealon, J.
Samson, S.
Salamand, C.
Loiacono, M. M.
Jensen, A. M. R.
Landler, N. E.
Claggett, B.
Solomon, S. D.
Gislason, G. H.
Koeber, L.
Biering-Soerensen, T.
EUROPEAN HEART JOURNAL, 2024, 45
[43] HIGH-DOSE INACTIVATED INFLUENZA VACCINE IS ASSOCIATED WITH COST SAVINGS AND BETTER OUTCOMES COMPARED TO STANDARD-DOSE INACTIVATED INFLUENZA VACCINE IN SENIORS
Chit, A.
Becker, D. L.
Diazgranados, C.
Maschio, M.
Yau, E.
Drummond, M.
VALUE IN HEALTH, 2015, 18 (03) : A240 - A240
[44] Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults? 60 years of age: Results from a phase III, randomized clinical trial
Sanchez, Leilani
Nakama, Takahiro
Nagai, Hideaki
Matsuoka, Osamu
Inoue, Satoshi
Inoue, Takahiro
Shrestha, Anju
Pandey, Aseem
Chang, Lee-Jah
De Bruijn, Iris
VACCINE, 2023, 41 (15) : 2553 - 2561
[45] High-dose trivalent influenza vaccine. Efficacy and effectiveness
Gil de Miguel, Angel
Redondo Marguello, Esther
Diez Domingo, Javier
Ortiz de Lejarazu, Raul
Martinon Torres, Federico
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2020, 33 (04) : 226 - 239
[46] Better outcomes with high-dose trivalent influenza vaccine in seniors
Machado, Marina A.
Moura, Cristiano S.
Abrahamowicz, Michal
Ward, Brian J.
Pilote, Louise
Bernatsky, Sasha
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 88 - 89
[47] Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease
Peikert, Alexander
Claggett, Brian L.
Udell, Jacob A.
Joseph, Jacob
Hegde, Sheila M.
Kim, KyungMann
Mao, Lu
Wang, Tuo
Havighurst, Thomas C.
Farkouh, Michael E.
Bhatt, Deepak L.
Tattersall, Matthew C.
Cooper, Lawton S.
Solomon, Scott D.
Vardeny, Orly
JAMA CARDIOLOGY, 2024, 9 (06) : 574 - 581
[48] High-dose trivalent inactivated influenza vaccine safe in elderly
Reactions Weekly, 2020, 1816 (1) : 7 - 7
[49] IFOSFAMIDE AND MESNA - RESPONSE AND TOXICITY AT STANDARD-DOSE AND HIGH-DOSE SCHEDULES
ANTMAN, KH
ELIAS, A
RYAN, L
SEMINARS IN ONCOLOGY, 1990, 17 (02) : 68 - 73
[50] Assessing Residual Bias in Estimating Influenza Vaccine Effectiveness Comparison of High-dose Versus Standard-dose Vaccines
Butler, Anne M.
Layton, J. Bradley
Krueger, Whitney S.
Kshirsagar, Abhijit V.
McGrath, Leah J.
MEDICAL CARE, 2019, 57 (01) : 73 - 78

← 1 2 3 4 5 →